Promising cure for COPD: is a breakthrough within reach?
2024年10月9日 · At this moment in time, there is no cure for the disease. But, after more than a decade with no new therapeutic advancements, interest in COPD seems to have grown in the last year, which can be evidenced by the recent regulatory approvals of Verona Pharma’s Ohtuvayre and Regeneron and Sanofi’s blockbuster drug Dupixent.
A New COPD Treatment is FDA Approved
2024年7月8日 · On June 26, 2024, Verona Pharmaceuticals announced that its new medication, Ensifentrine (Ohtuvayre), was approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). See the press release here. Ensifentrine works in two main ways to help people breathe better:
5 New Medical Breakthroughs for COPD Patients - WebMD
2019年2月6日 · Researchers are working on new therapies to treat the symptoms of chronic obstructive pulmonary disease (COPD), like shortness of breath, lung inflammation, and chronic cough. Some are already...
FDA Approves Dupilumab as First Biologic Treatment for COPD
2024年9月27日 · The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to...
Breakthrough COPD Treatments: A New Hope (2024) - DVC Stem
2024年6月5日 · New treatments for COPD (Chronic Obstructive Pulmonary Disease) are being developed to address the disease's progression and improve the quality of life for patients. Some of the newest treatments include: Losmapimod: A p38 MAPK inhibitor that has shown efficacy and safety in a randomized, double-blind, placebo-controlled trial.
What Is the Latest Treatment for COPD? - MedicineNet
Chronic obstructive pulmonary disease or COPD is a difficult disease to treat with no known cure. However, with recent developments in the medical field, more tools at their disposal, and more knowledge about cellular functions, researchers are exploring new treatment options.
Dupixent as New Treatment for COPD - HealthCentral
2024年9月27日 · Dupixent is the first newly approved treatment for COPD in more than a decade. Published data from the Phase 3 NOTUS clinical trial confirmed previous findings that showed how the...
Biologics for COPD — Finally Here | New England Journal of …
2023年7月19日 · In respiratory medicine, monoclonal antibodies have already transformed the management of severe asthma. 1 By contrast, previous trials of biologic agents targeting interleukin-5 have yielded...
COPD News - ScienceDaily
4 天之前 · Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...
Update on the pharmacological treatment of chronic obstructive ...
Recent major advancements in the treatment of COPD patients have become available. Areas covered: New data on the role of classic bronchodilators, including short-acting and long-acting beta2-agonists and anti-muscarinic antagonists, in the treatment of COPD patients are discussed.